Loss of HMGCS2 Enhances Lipogenesis and Attenuates the Protective Effect of the Ketogenic Diet in Liver Cancer

Hepatocellular carcinoma (HCC) is the most common primary malignant liver tumor with limited treatment. The ketogenic diet (KD) emerged as a metabolic therapy for cancer; however, the antitumor effect on HCC remains controversial. We previously reported that the ketogenesis rate-limiting enzyme, 3-h...

Full description

Bibliographic Details
Main Authors: Yuan-Hsi Wang, Fat-Moon Suk, Yi-Jen Liao
Format: Article
Language:English
Published: MDPI AG 2020-07-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/12/7/1797
_version_ 1797563293225713664
author Yuan-Hsi Wang
Fat-Moon Suk
Yi-Jen Liao
author_facet Yuan-Hsi Wang
Fat-Moon Suk
Yi-Jen Liao
author_sort Yuan-Hsi Wang
collection DOAJ
description Hepatocellular carcinoma (HCC) is the most common primary malignant liver tumor with limited treatment. The ketogenic diet (KD) emerged as a metabolic therapy for cancer; however, the antitumor effect on HCC remains controversial. We previously reported that the ketogenesis rate-limiting enzyme, 3-hydroxymethylglutaryl-CoA synthase 2 (HMGCS2), was downregulated in most patients with HCC. The knockdown of HMGCS2 enhanced the proliferation and metastasis ability of HCC cells. However, the role of HMGCS2 in affecting KD-mediated metabolic effects remains unclear. Here, we report that KD feeding upregulates HMGCS2 expression and inhibits HCC tumor growth, while a reverse correlation between tumor size and HMGCS2 expression was observed. We found that HCC cells with HMGCS2 downregulation possess altered lipid metabolism that increases fatty acid, triglyceride, and cholesterol synthesis. Under KD feeding, a higher tumor growth rate was observed in HMGCS2 knockdown tumors, which had increased lipid synthesis-related marker expression and a positive correlation between lipid quantity and tumor weight. In conclusion, these results demonstrate that the downregulation of HMGCS2 attenuates the protective effect of the KD by shifting ketone production to enhance de novo lipogenesis in HCC. Our study elucidates a new molecular mechanism underlying the crosstalk between HMGCS2 expression and the KD in cancer treatment, which provides more information for precision medicine in developing personalized treatment strategies.
first_indexed 2024-03-10T18:40:35Z
format Article
id doaj.art-7272d788a5f449e1bd94421a10fa06c1
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-10T18:40:35Z
publishDate 2020-07-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-7272d788a5f449e1bd94421a10fa06c12023-11-20T05:52:43ZengMDPI AGCancers2072-66942020-07-01127179710.3390/cancers12071797Loss of HMGCS2 Enhances Lipogenesis and Attenuates the Protective Effect of the Ketogenic Diet in Liver CancerYuan-Hsi Wang0Fat-Moon Suk1Yi-Jen Liao2School of Medical Laboratory Science and Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei 110, TaiwanDivision of Gastroenterology, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei 116, TaiwanSchool of Medical Laboratory Science and Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei 110, TaiwanHepatocellular carcinoma (HCC) is the most common primary malignant liver tumor with limited treatment. The ketogenic diet (KD) emerged as a metabolic therapy for cancer; however, the antitumor effect on HCC remains controversial. We previously reported that the ketogenesis rate-limiting enzyme, 3-hydroxymethylglutaryl-CoA synthase 2 (HMGCS2), was downregulated in most patients with HCC. The knockdown of HMGCS2 enhanced the proliferation and metastasis ability of HCC cells. However, the role of HMGCS2 in affecting KD-mediated metabolic effects remains unclear. Here, we report that KD feeding upregulates HMGCS2 expression and inhibits HCC tumor growth, while a reverse correlation between tumor size and HMGCS2 expression was observed. We found that HCC cells with HMGCS2 downregulation possess altered lipid metabolism that increases fatty acid, triglyceride, and cholesterol synthesis. Under KD feeding, a higher tumor growth rate was observed in HMGCS2 knockdown tumors, which had increased lipid synthesis-related marker expression and a positive correlation between lipid quantity and tumor weight. In conclusion, these results demonstrate that the downregulation of HMGCS2 attenuates the protective effect of the KD by shifting ketone production to enhance de novo lipogenesis in HCC. Our study elucidates a new molecular mechanism underlying the crosstalk between HMGCS2 expression and the KD in cancer treatment, which provides more information for precision medicine in developing personalized treatment strategies.https://www.mdpi.com/2072-6694/12/7/1797HMGCS2ketogenic dietlipogenesishepatocellular carcinoma
spellingShingle Yuan-Hsi Wang
Fat-Moon Suk
Yi-Jen Liao
Loss of HMGCS2 Enhances Lipogenesis and Attenuates the Protective Effect of the Ketogenic Diet in Liver Cancer
Cancers
HMGCS2
ketogenic diet
lipogenesis
hepatocellular carcinoma
title Loss of HMGCS2 Enhances Lipogenesis and Attenuates the Protective Effect of the Ketogenic Diet in Liver Cancer
title_full Loss of HMGCS2 Enhances Lipogenesis and Attenuates the Protective Effect of the Ketogenic Diet in Liver Cancer
title_fullStr Loss of HMGCS2 Enhances Lipogenesis and Attenuates the Protective Effect of the Ketogenic Diet in Liver Cancer
title_full_unstemmed Loss of HMGCS2 Enhances Lipogenesis and Attenuates the Protective Effect of the Ketogenic Diet in Liver Cancer
title_short Loss of HMGCS2 Enhances Lipogenesis and Attenuates the Protective Effect of the Ketogenic Diet in Liver Cancer
title_sort loss of hmgcs2 enhances lipogenesis and attenuates the protective effect of the ketogenic diet in liver cancer
topic HMGCS2
ketogenic diet
lipogenesis
hepatocellular carcinoma
url https://www.mdpi.com/2072-6694/12/7/1797
work_keys_str_mv AT yuanhsiwang lossofhmgcs2enhanceslipogenesisandattenuatestheprotectiveeffectoftheketogenicdietinlivercancer
AT fatmoonsuk lossofhmgcs2enhanceslipogenesisandattenuatestheprotectiveeffectoftheketogenicdietinlivercancer
AT yijenliao lossofhmgcs2enhanceslipogenesisandattenuatestheprotectiveeffectoftheketogenicdietinlivercancer